ArticlePediatric nephrology (Berlin, Germany)2021

Regarding: A global anti-B cell strategy combining obinutuzumab and daratumumab in severe pediatric nephrotic syndrome.

Alan Majeranowski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.